ReShape Lifesciences Inc (RSLS)       0.5603  -0.02 (-2.86%)

0.5603  -0.02 (-2.86%)

US76090R1014 - Common Stock - After market: 0.58 +0.02 (+3.52%)

Buy % Consensus

Analysts have set a mean price target of 3.9. This target is 596.32% above the current price.
RSLS was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RSLS.
In the previous month the buy percentage consensus was at a similar level.
RSLS was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 0.563.033.903.904.88 - 440.78% 596.32% 596.32% 771.41%

Up and Down Grades

Date Firm Action Rating
2022-05-26 Alliance Global Partners Maintains Buy
2021-10-08 Maxim Group Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA